Abstract

Obtaining informed consent (IC) is an ethical imperative, signifying participants’ understanding of the conditions and implications of research participation. One setting where the stakes for understanding are high is randomized controlled trials (RCTs), which test the effectiveness and safety of medical interventions. However, the use of legalese and medicalese in ethical forms coupled with the need to explain RCT-related concepts (e.g. randomization) can increase patients’ cognitive load when reading text. There is a need to systematically examine the language demands of IC documents, including whether the processes intended to safeguard patients by providing clear information might do the opposite through complex, inaccessible language. Therefore, the goal of this study is to build an open-access corpus of patient information sheets (PIS) and consent forms (CF) and analyze each genre using an interdisciplinary approach to capture multidimensional measures of language quality beyond traditional readability measures. A search of publicly-available online IC documents for UK-based cancer RCTs (2000-17) yielded corpora of 27 PIS and 23 CF. Textual analysis using the computational tool, Coh-Metrix, revealed different linguistic dimensions relating to the complexity of IC documents, particularly low word concreteness for PIS and low referential and deep cohesion for CF, although both had high narrativity. Key part-of-speech analyses using Wmatrix corpus software revealed a contrast between the overrepresentation of the pronoun ‘you’ plus modal verbs in PIS and ‘I’ in CF, exposing the contradiction inherent in conveying uncertainty to patients using tentative language in PIS while making them affirm certainty in their understanding in CF.

Highlights

  • Obtaining informed consent (IC) for research involving participants is an ethical imperative, legal requirement, and widely accepted international standard (World Medical Association, 2013)

  • The initial search yielded 863 records after removing duplicates, which were screened for the inclusion criteria, resulting in 263 randomized controlled trials (RCTs) before the criterion of the availability of the patient information sheets (PIS) or consent forms (CF) online was applied

  • This resulted in a 62,030-word corpus of 27 PIS and an 8118-word corpus of 23 CF drawn from 28 RCTs

Read more

Summary

Introduction

Obtaining informed consent (IC) for research involving participants is an ethical imperative, legal requirement, and widely accepted international standard (World Medical Association, 2013). One setting where the stakes for understanding are high in view of the potential consequences of research participation is clinical trials, which test the effectiveness and safety of new medical interventions for patients. Much of the IC literature, resides in the trials methodology research, including randomized controlled trials (RCTs), which are widely regarded as the most robust method for making causal inferences between an intervention and outcome in medicine (Cockayne et al, 2017). The biggest challenge with IC in clinical trials is how to provide meaningful information in a way that potential participants can understand and use to make a decision about their participation in the study

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call